Portola Pharma (PTLA) Tops Q1 EPS by 14c

Portola Pharma (NASDAQ: PTLA) reported Q1 EPS of ($0.95), $0.14 better than the analyst estimate of ($1.09). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery